在老年人中治疗慢性便秘的Ileal胆酸载体抑制剂
Payila Satya Raghava Aneesh1, Venkatesh Vaithiyam2, Ravi Teja Reddy1
1Department of Gastroenterology, Govind Ballabh Pant Institute of Post Graduate Medical Education and Research, New Delhi 110002, Delhi, India.
Abstract:
我们饶有兴趣地阅读并赞赏Sakai等针对老年慢性便秘(CC)患者使用艾洛匹巴特疗效的重要研究,我们深表感谢。该研究为艾洛匹巴特在老年CC患者中的安全性和有效性提供了宝贵的见解。然而,我们对该研究在方法学及对老年群体CC评估方面有若干关键意见。作者未就可能存在的药物相关性便秘进行说明,因其大多数老年患者伴有共病、便秘的结构性病因,且缺乏对胃肠道动力的评估;我们主张对老年患者的CC应进行更为全面的检查评估。本文还系统综述了老年慢性便秘的评估流程,以及关于回肠胆汁酸转运蛋白抑制剂——艾洛匹巴特在慢性便秘中应用的现有证据。
更多相关视频
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...


